Despite its accuracy, Sanger sequencing has limitations. It is relatively slow and expensive compared to newer sequencing technologies like next-generation sequencing (NGS). Additionally, it is less suited for sequencing large genomes or detecting low-frequency variants in heterogeneous samples. These limitations can be a drawback in large-scale epidemiological studies.
